💥 Dragon Pharma

Vesugen

✔️ Substance: Bioregulator Peptide
✔️ Price For: Vial 20 mg
✔️ Brand: Dragon Pharma

Out of stock

Dragon Pharma Vesugen

IDENTITYCompoundVesugen Bioregulator Peptide
CategoryPeptide Bioregulator
Strength20 mg
FormLyophilized Peptide Vial
BrandDragon Pharma

PEPTIDE PROFILEClassEpigenetic Peptide Complex
SourceShort-chain Bioregulator Peptide
Primary TargetCardiovascular Tissue Regulation
Research AreaCellular Function & Aging Research
AdministrationSubcutaneous (SC)

PHARMACOLOGYMechanismPeptide Signal Regulation
ActivityGene Expression Modulation
Tissue FocusCardiovascular System
Hormonal EffectNon-Androgenic
Liver ImpactLow Expected Impact

STORAGE & PACKAGEBrandDragon Pharma
Package20 mg Multi-dose Vial
Storage Before Use2–8°C Recommended
After ReconstitutionRefrigerated Storage
Protect FromLight & Heat

ADMINISTRATION PROFILERouteSubcutaneous Injection
UsagePeptide Support Protocol
Injection TimeMorning or Evening
FrequencyDaily Administration
Cycle Length4–12 Weeks

DOSING INFORMATIONBeginner5 mg/week
Intermediate10 mg/week
Advanced10–20 mg/week
Administration Split Daily or Multiple Weekly Use
Typical Duration4–12 Weeks

BODYBUILDING USAGEPurposeRecovery & Cellular Support
Training PhaseBulking / Cutting Support
Usage TimeUsually 4–8 Weeks
Daily ApproachLow-dose Peptide Administration
Combination Compatible With Recovery Protocols

RECOVERY & DISCONTINUATION PCT RequiredNo Classical PCT
Hormonal SuppressionNot Expected
Stopping TimeAfter Planned Cycle Completion
RecoveryGradual Cellular Adaptation
MonitoringGeneral Health Markers

COMPATIBILITYRecovery StackGH Peptides / Recovery Compounds
Training SupportNutrition & Resistance Training
Cutting PhaseFat Loss Programs
Bulking PhaseMuscle Growth Programs
SupportSleep & Recovery Optimization

MECHANISM OF ACTIONTargetCellular Regulatory Pathways
ActionPeptide Signaling Modulation
ExpressionInfluence On Gene Activity
TissueCardiovascular Cellular Environment
EffectBioregulation Support

PHARMACOKINETICSAbsorptionSubcutaneous Peptide Uptake
DistributionSystemic Peptide Availability
MetabolismPeptide Enzymatic Breakdown
Half-lifeLimited Human Data Available
ClearancePeptide Metabolism Pathways

SAFETY PROFILEHormonal ImpactNon-Steroidal Profile
Liver ToxicityNot Associated With Oral Steroid Effects
Injection RiskRequires Sterile Administration
MonitoringGeneral Medical Assessment
Research StatusLimited Clinical Data

CONTRAINDICATIONSPregnancyNot Recommended
AllergyAvoid If Peptide Hypersensitivity
Medical ConditionsProfessional Evaluation Required
Injection SiteMonitor Reactions
MedicationReview Drug Interactions

CHEMICAL PROFILECompoundVesugen Peptide Bioregulator
FormulaSpecific Sequence Dependent
Molecular WeightPeptide Sequence Dependent
ClassShort Peptide Bioregulator
CASNot Established

USAGE FEATURESStart Phase Beginning Of Recovery Protocol
Active Period4–12 Weeks
Daily RoutineConsistent Administration Schedule
Support GoalCellular Maintenance
ApproachLong-Term Support Strategy

PROTOCOL FEATURESWeek 1–2Adaptation Phase
Week 3–8Active Support Phase
Week 8+Extended Monitoring Phase
Injection TimeDaily Scheduled Administration
StabilityRequires Proper Storage

PERFORMANCE PROFILE

Recovery Support

78%

Cellular Support

75%

Fat Loss Support

55%

Muscle Preservation

65%

Hormonal Activity

20%

OVERVIEW

Vesugen is a bioregulator peptide developed within the field of peptide research focusing on cellular communication and tissue-specific regulation. Unlike anabolic steroids, Vesugen does not function through androgen receptor activation and does not provide direct anabolic hormone activity.

BENEFITS

Peptide-based cellular regulation support
Non-androgenic profile
Recovery protocol compatibility
Cardiovascular research interest
Supports structured wellness approaches
No classical anabolic suppression

POTENTIAL RISKS

Limited human clinical evidence
Possible injection site reactions
Individual peptide sensitivity
Unknown long-term effects
Need for sterile handling
Quality variation between sources

WHAT IS DRAGON PHARMA?

Dragon Pharma is a pharmaceutical-oriented brand known in the bodybuilding and sports performance market for producing a range of research compounds, peptides, and performance-related products. The brand name is commonly associated with products designed for athletes, fitness users, and research-focused communities.

Dragon Pharma products are typically presented with emphasis on manufacturing consistency, product identification, and professional packaging standards. As with all peptide products, users should evaluate product quality, storage requirements, and applicable regulations before use.

WHY CHOOSE DRAGON PHARMA

Dragon Pharma products are selected by many bodybuilding readers because of their recognizable branding, structured product presentation, and availability of specialized compounds such as peptide bioregulators.

For products like Vesugen 20 mg, proper handling, correct storage, accurate identification, and responsible research practices are important factors when evaluating any peptide-based product.

CONCLUSION

Dragon Pharma Vesugen 20 mg is a peptide bioregulator product designed around the concept of tissue-specific cellular regulation. Unlike anabolic-androgenic steroids, Vesugen does not act as a testosterone derivative and does not produce direct androgen-mediated muscle growth.

For bodybuilding audiences, Vesugen is mainly discussed as a recovery-support peptide due to interest in cellular maintenance, cardiovascular support research, and long-term physiological optimization strategies combined with proper training and nutrition.

Within bodybuilding communities, Vesugen is mainly discussed as a recovery and cellular support compound used alongside structured training, nutrition, sleep optimization, and general performance strategies. Current scientific understanding of peptide bioregulators continues to develop, and available clinical evidence remains more limited compared with established pharmaceutical therapies.

Appropriate storage, sterile administration practices, and responsible evaluation of scientific evidence are essential considerations when discussing peptide compounds.

DISCLAIMER

This content is provided exclusively for educational and informational purposes. It does not constitute medical advice, diagnosis, treatment recommendations, or endorsement of non-approved pharmaceutical use. Peptide compounds should be evaluated according to scientific evidence, applicable regulations, and professional healthcare guidance.